Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.60 |
| ▸ | CA4 | P22748 | 1/20 | 0.60 |
| ▸ | MME | P08473 | 6/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | CASP3 | P42574 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.39 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29238597 | 1.00 | CA2 (0.60) | CA2CA4MMERECQLSMN1; SMN2 | |
| SCHEMBL29203958 | 1.00 | CA2 (0.60) | CA2CA4MMERECQLSMN1; SMN2 | |
| SCHEMBL4572564 | 0.84 | CA2 (0.62) | CA2CA4MMERECQLSMN1; SMN2 | |
| SCHEMBL13674348 | 0.84 | CA2 (0.62) | CA2CA4MMERECQLSMN1; SMN2 | |
| SCHEMBL3510050 | 0.83 | ECE1 (0.50) | CA2CA4MMECA1 | |
| SCHEMBL3510048 | 0.83 | ECE1 (0.50) | CA2CA4MMECA1 | |
| SCHEMBL4177568 | 0.82 | CA2 (0.60) | CA2CA4MMERECQLSMN1; SMN2 | |
| SCHEMBL15605900 | 0.82 | CA2 (0.60) | CA2CA4MMERECQLSMN1; SMN2 | |
| SCHEMBL4177566 | 0.82 | CA2 (0.60) | CA2CA4MMERECQLSMN1; SMN2 | |
| SCHEMBL4812263 | 0.81 | TGFBR1 (0.56) | CA2CA4MMERECQLSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121586705-A | Small molecule prostaglandin F receptor antagonists | 辉凌公司 | 2026-02-27 | — | — | CN | disclosed |
| CN-116322673-B | Radiolabeled compounds | 伦敦国王学院 | 2025-06-10 | — | — | CN | disclosed |
| CN-115989224-B | Plasma kallikrein inhibitors | 默沙东有限责任公司 | 2025-02-25 | — | — | CN | disclosed |
| CN-119013301-A | Binding agents that bind EPCAM and/or CD137 | 根马布股份公司 | 2024-11-22 | — | — | CN | disclosed |
| CN-118894908-A | Multi-targeting compounds and uses thereof | 成都社泰医疗科技有限公司 | 2024-11-05 | — | — | CN | disclosed |
| CN-118434455-A | Near infrared fluorescence contrast biological imaging agent for sentinel lymph node imaging | 库拉代尔外科创新公司 | 2024-08-02 | — | — | CN | disclosed |
| CN-113272293-B | 2-Amino-N-heteroaryl-nicotinamide as NAV1.8 inhibitor | 默沙东有限责任公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-118146196-A | FAP inhibitors | 海德堡大学 | 2024-06-07 | — | — | CN | disclosed |
| CN-118084700-A | Amino acid derivative and application thereof | 贵州医科大学 | 2024-05-28 | — | — | CN | disclosed |
| CN-112367982-B | Amide compounds, compositions and methods of treatment as kinase inhibitors | 转化药物开发有限责任公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-116535365-A | Macrocyclic diamine derivatives and their combination with adenosine receptor antagonists as ENT inhibitors for the treatment of cancer | ITEOS比利时公司 | 2023-08-04 | — | — | CN | disclosed |
| CN-116322673-A | Radiolabeled compounds | 伦敦国王学院 | 2023-06-23 | — | — | CN | disclosed |
| CN-116143690-A | PET imaging for soluble epoxide hydrolase (sEH) 18 F-FNDP | 约翰霍普金斯大学 | 2023-05-23 | — | — | CN | disclosed |
| CN-115989224-A | Plasma kallikrein inhibitors | 默沙东有限责任公司 | 2023-04-18 | — | — | CN | disclosed |
| CN-115884767-A | Administration of SUMO activating enzyme inhibitors and anti-CD 38 antibodies | 武田药品工业株式会社 | 2023-03-31 | — | — | CN | disclosed |
| CN-115768773-A | Macrocyclic diamine derivatives as ENT inhibitors for the treatment of cancer and combinations thereof with adenosine receptor antagonists | ITEOS比利时公司 | 2023-03-07 | — | — | CN | disclosed |
| CN-107567442-B | Inhibitors of hepatitis C virus polymerase | 共晶制药公司 | 2021-05-25 | — | — | CN | disclosed |
| CN-111658630-B | Application of rosmarinic acid C in preparation of medicine for preventing and/or treating epilepsy | 温州医科大学附属第一医院 | 2021-03-23 | — | — | CN | disclosed |
| CN-111658630-A | Application of rosmarinic acid C in preparation of medicine for preventing and/or treating epilepsy | 温州医科大学附属第一医院 | 2020-09-15 | — | — | CN | disclosed |
| CN-111328280-A | Methods of making and using endoxifen | 阿托萨治疗学公司 | 2020-06-23 | — | — | CN | disclosed |